Delisting riskPopularity #4,297
Advanced Biomed (ADVB)
Financial-market AI systems with biomedical R&D pending sale.
$6.46
vs last close+0.08 (+1.25%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Insiders | 12.75% | 176.2K shares | |
|---|---|---|---|
| 1 holder · as of Aug 20, 2026 | |||
| Strategic holders | 7.90% | 109.2K shares | |
| 1 holder · as of Sep 22, 2026 | |||
| Other | 79.35% | 1.10M shares | |
| remainder | |||
1.38M company shares as of Sep 23, 2026 · holders as of their latest filing
13F
No 13F holders on record.
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Pau Hung To | 12.75% | 176.2K | 13G | Aug 20, 2026 |
| ADVANCE ON VENTURES Ltd | 6.60% | 109.2K | 13G | Sep 22, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.